Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
London
· Delayed Price · Currency is GBP · Price in USD 15.67
-0.80 (-4.85%)
At close: Jun 13, 2025
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of 1.60 billion as of June 16, 2025. Its market cap has decreased by -28.43% in one year.
Market Cap
1.60B
Enterprise Value
1.34B
Revenue
421.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.67
Market Cap Chart
Since January 13, 2004, Arrowhead Pharmaceuticals's market cap has increased from 17.94M to 1.60B, an increase of 8,810.91%. That is a compound annual growth rate of 23.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 170.36B |
| GSK plc | 61.23B |
| Haleon | 35.62B |
| Smith & Nephew | 9.57B |
| ConvaTec Group | 5.88B |
| Hikma Pharmaceuticals | 4.69B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.30B |